Efficacy and Safety of Tyrosine Kinase Inhibitor Combined With Venetoclax-Based Regimen in Pediatric Patients With Chronic Myeloid Leukemia in the Blast Phase: A Single-Center Retrospective Study
{{output}}
Background: Pediatric chronic myeloid leukemia in the blast phase (CML-BP) is rare and high-risk, requiring early hematopoietic stem cell transplantation (HSCT). Tyrosine kinase inhibitor (TKI) combined with intensive chemotherap... ...
